87 related articles for article (PubMed ID: 2664444)
1. [Preventive effect of OP-41483-alpha-CD on cyclosporine A-induced renal tubular and arterial damages].
Kobayashi M
Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):187-98. PubMed ID: 2664444
[TBL] [Abstract][Full Text] [Related]
2. Effect of a stable analogue of prostacyclin on cyclosporine A-induced nephrotoxicity: morphological qualitative and quantitative studies.
Kobayashi M; Takaya S; Koie H
Transplant Proc; 1988 Feb; 20(1 Suppl 1):183-6. PubMed ID: 3279609
[No Abstract] [Full Text] [Related]
3. [The effect of prostacyclin analog (OP-41483) on pulmonary oxygen toxicity in isolated heart-lung autoperfusion model].
Arima T; Ueda K; Hatanaka M; Omoto R; Matsumoto I; Hori T
Masui; 1988 Jun; 37(6):661-6. PubMed ID: 3063845
[No Abstract] [Full Text] [Related]
4. Renal tubular transport of cyclosporine A (CSA) and associated changes in renal function.
Caterson RJ; Duggin GG; Critchley L; Baxter C; Horvath JS; Hall BM; Tiller DJ
Clin Nephrol; 1986; 25 Suppl 1():S30-3. PubMed ID: 3519028
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin I2 analogue and propranolol prevent ischaemia induced mitochondrial dysfunction through the stabilisation of lysosomal membranes.
Hieda N; Toki Y; Sugiyama S; Ito T; Satake T; Ozawa T
Cardiovasc Res; 1988 Mar; 22(3):219-25. PubMed ID: 3048692
[TBL] [Abstract][Full Text] [Related]
6. Acute cyclosporine A nephrotoxicity in rats: which role for renin-angiotensin system and glomerular prostaglandins?
Perico N; Benigni A; Bosco E; Rossini M; Orisio S; Ghilardi F; Piccinelli A; Remuzzi G
Clin Nephrol; 1986; 25 Suppl 1():S83-8. PubMed ID: 3519031
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine-induced renal structural damage: influence of dosage, strain, age and sex with reference to the rat and guinea pig.
Duncan JI; Thomson AW; Aldridge RD; Simpson JG; Whiting PH
Clin Nephrol; 1986; 25 Suppl 1():S14-7. PubMed ID: 3708924
[TBL] [Abstract][Full Text] [Related]
8. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats.
Louhelainen M; Merasto S; Finckenberg P; Lapatto R; Cheng ZJ; Mervaala EM
J Hypertens; 2006 May; 24(5):947-56. PubMed ID: 16612258
[TBL] [Abstract][Full Text] [Related]
9. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of incorporating cyclosporine into liposomes to reduce its nephrotoxicity.
Smeesters C; Giroux L; Vinet B; Arnoux R; Chaland P; Corman J; St-Louis G; Daloze P
Can J Surg; 1988 Jan; 31(1):34-6. PubMed ID: 3257403
[TBL] [Abstract][Full Text] [Related]
11. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats.
Hagar HH; El Etter E; Arafa M
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):189-96. PubMed ID: 16487261
[TBL] [Abstract][Full Text] [Related]
12. Morphology of cyclosporine nephrotoxicity in the rat.
Mihatsch MJ; Ryffel B; Hermle M; Brunner FP; Thiel G
Clin Nephrol; 1986; 25 Suppl 1():S2-8. PubMed ID: 3708932
[TBL] [Abstract][Full Text] [Related]
13. Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.
del Moral RG; Andujar M; Ramírez C; Gómez-Morales M; Masseroli M; Aguilar M; Olmo A; Arrebola F; Guillén M; García-Chicano MJ; Nogales FF; O'Valle F
Am J Pathol; 1997 Dec; 151(6):1705-14. PubMed ID: 9403721
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.
Pérez-Rojas J; Blanco JA; Cruz C; Trujillo J; Vaidya VS; Uribe N; Bonventre JV; Gamba G; Bobadilla NA
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F131-9. PubMed ID: 16835406
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of tea polyphenols on renal cell apoptosis in rat test subjects suffering from cyclosporine-induced chronic nephrotoxicity.
Shi S; Zheng S; Zhu Y; Jia C; Xie H
Chin Med J (Engl); 2003 Sep; 116(9):1345-50. PubMed ID: 14527363
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A-induced kidney alterations are limited by melatonin in rats: an electron microscope study.
Stacchiotti A; Lavazza A; Rezzani R; Bianchi R
Ultrastruct Pathol; 2002; 26(2):81-7. PubMed ID: 12036096
[TBL] [Abstract][Full Text] [Related]
17. PGE2 reduces nephrotoxicity and immunosuppression of cyclosporine in rats.
Ryffel B; Donatsch P; Hiestand P; Mihatsch MJ
Clin Nephrol; 1986; 25 Suppl 1():S95-9. PubMed ID: 3458551
[TBL] [Abstract][Full Text] [Related]
18. Polymerized type I collagen reduces chronic cyclosporine nephrotoxicity.
Sánchez-Pozos K; Lee-Montiel F; Pérez-Villalva R; Uribe N; Gamba G; Bazan-Perkins B; Bobadilla NA
Nephrol Dial Transplant; 2010 Jul; 25(7):2150-8. PubMed ID: 20139407
[TBL] [Abstract][Full Text] [Related]
19. Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
Fujishiro J; Suzuki C; Kudou S; Yasue T; Hakamata Y; Takahashi M; Murakami T; Hashizume K; Kobayashi E
J Heart Lung Transplant; 2006 Jul; 25(7):825-33. PubMed ID: 16818126
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine nephrotoxicity in the Fischer rat.
Verani R
Clin Nephrol; 1986; 25 Suppl 1():S9-13. PubMed ID: 3708942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
